Medicines

WHO Programme for International Drug Monitoring

As of August 2011, 106 countries have joined the WHO Pharmacovigilance (PV) Programme, and in addition 33 associated members are awaiting for full membership. The aims of PV are to enhance patient care and patient safety in relation to the use of medicines; and to support public health programmes by providing reliable, balanced information for the effective assessment of the risk-benefit profile of medicines. This Programme includes:

  • 106 full members (dark blue)
  • 33 Associate Members (light blue)
  • A WHO Collaborating Center: UMC (purple)


View WHO Programme for International Drug Monitoring in a larger map

back to the National Pharmacovigilance Centres page

Share